Overview | Enovis Future

Overview

// OUR EXCITING FUTURE — TOGETHER!

Great News

We are excited to announce our intention to acquire LimaCorporate, a privately-held global orthopedic leader focused on restoring motion through digital innovation and customized hardware.

  • Based in Italy, LimaCorporate expands our global footprint, strengthens our manufacturing capabilities and enhances our innovation pipeline.
  • The strategic combination of LimaCorporate and Enovis creates a “new” global leader with scale in orthopedics.
  • We are combining two powerful innovation engines with proven leadership across joint reconstruction!
  • Together, we will continue to be focused on building a high-value medical technology growth company that improves patient outcomes, drives growth through innovation, incorporates the best M&A opportunities, and develops extraordinary talent.

What This Means for Enovis and LimaCorporate

GROWTH. OPPORTUNITY. STRENGTH.

  • Accelerates Recon to $1B segment and ensures our goal of growing to $2 billion revenue in 2024
  • Establishes a powerful international surgical business by expanding market share and creates growth opportunities through a complementary global footprint and product lines
  • Generates opportunities to invest in and scale our combined supply chain, innovation engine, and commercial teams
  • Creates broader career development and growth opportunities

Our patient commitment is unwavering. Together, we will continue to build a high-value medical technology growth company that improves patient outcomes!

About This Site

This website has been created to keep current and future Enovis employees informed as we move through the acquisition and integration process, including providing answers to questions you might have. As a reminder, this acquisition is targeted to close by early 2024 and is conditioned on the receipt of applicable regulatory approvals and other customary closing conditions.

© Enovis Corporation 2024

en_USEnglish